Caribou Biosciences, Inc. (CRBU)
0.4647
0.00 (0.00%)
USD |
NASDAQ |
Oct 15, 16:00
0.4666
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences Cash from Operations (TTM) : -95.78M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -95.78M |
| March 31, 2026 | -101.25M |
| December 31, 2025 | -110.99M |
| September 30, 2025 | -125.64M |
| June 30, 2025 | -133.11M |
| March 31, 2025 | -137.72M |
| December 31, 2024 | -138.20M |
| September 30, 2024 | -124.11M |
| June 30, 2024 | -120.24M |
| March 31, 2024 | -102.56M |
| December 31, 2023 | -93.29M |
| September 30, 2023 | -96.96M |
| Date | Value |
|---|---|
| June 30, 2023 | -90.54M |
| March 31, 2023 | -97.23M |
| December 31, 2022 | -90.97M |
| September 30, 2022 | -87.31M |
| June 30, 2022 | -79.90M |
| March 31, 2022 | -74.50M |
| December 31, 2021 | -32.52M |
| September 30, 2021 | -19.21M |
| June 30, 2021 | -12.93M |
| March 31, 2021 | -3.659M |
| December 31, 2020 | -33.22M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Intellia Therapeutics, Inc. | -346.64M |
| Vir Biotechnology, Inc. | -202.51M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |